- Home
- MNPR vs PFIS Comparison
MNPR vs PFIS Comparison
Compare MNPR & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNPR | PFIS |
|---|---|---|
| Founded | 2014 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 372.9M | 499.8M |
| IPO Year | 2019 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MNPR | PFIS |
|---|---|---|
| Price | $55.74 | $51.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | ★ $101.42 | $56.00 |
| AVG Volume (30 Days) | ★ 150.5K | 29.5K |
| Earning Date | 01-01-0001 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 4.69 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.01 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | $11.04 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.06 | $39.00 |
| 52 Week High | $105.00 | $57.71 |
Technical Indicators
Market Signals| Indicator | MNPR | PFIS |
|---|---|---|
| Relative Strength Index (RSI) | 45.47 | 41.16 |
| Support Level | $56.15 | $50.56 |
| Resistance Level | $61.30 | $53.27 |
| Average True Range (ATR) | 3.32 | 1.95 |
| MACD | 0.75 | -0.51 |
| Stochastic Oscillator | 53.45 | 21.67 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.